al., Curr Microbiol., 76:
762-773 (2019).
3. Yang L. and Li Y., J Food Prot., 68:
1241–45 (2005).
4. Lo Fo Wong DMA., et al., Livest Prod Sci., 76:
215–22 (2002).
5. Ridley
and antifolates in
methotrexate-sensitive and -resistant leukemia cells. Adv. Enzyme Regul. 37, 59-76 (1997)
16. Huennekens, F.M., The methotrexate story: a paradigm for development of cancer
chemotherapeutic
Enzymol., 165, 76-85 (1988).
4. Knight, D. E., Botulinum toxin types A, B and D
inhibit catecholamine secretion from bovine
adrenal medullary cells. FEBS Lett., 207(2), 222-
226 (1986).
5. Argoff
and
antifolates in methotrexate-sensitive and -
resistant leukemia cells. Adv. Enzyme
Regul. 37, 59-76 (1997)
16. Huennekens, F.M., The methotrexate story:
a paradigm for development of cancer
chemotherapeutic
dismutase mimic and protects cultured lens
epithelial cells from H2O2 insult. Exp. Eye Res.,
76(1), 49-59 (2003).
7. Joet, T., et al., Involvement of a plastid terminal
oxidase in plastoquinone
R. Liss., New York, pp. 61-75 (1989).
5. King, S., et al., J. Biol. Chem., 266, 8401-8407
(1991).
6. Vallee, R., and Shpetner, H., Ann. Rev. Biochem.,
59, 909-932 (1990).
Pcs4/01
Sigma brand
Ruth, "Hox function in
mammalian kidney development". University of
Michigan, Ph.D. dissertation, p. 76 (2009).
8. Gao, Yin, "Glycosylation of prostate cancer cell
lines and glycosyltransferase characterization
Patchy Particle
Self-Assembly". University of Pennsylvania, Ph.D.
dissertation, pp. 36, 44, 48, 76 (2015).
18. Nicholes, Nathan, "Improved Methods for the
Development and Adaptation of Protein
J., and Weiss, R. A., Cell, 52, 631 (1988).
Reinherz, E. L., et al., Proc. Natl. Acad. Sci. U.S.A, 76,
4061 (1979).
Biddison, W. E., et al., J. Immunol., 131, 152 (1983).
Maddon, P. J., et al., Cell